Legacy Wealth Management LLC MS Has $2.94 Million Stake in UnitedHealth Group Incorporated $UNH

Legacy Wealth Management LLC MS cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 30.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,910 shares of the healthcare conglomerate’s stock after selling 3,970 shares during the period. UnitedHealth Group makes up 0.8% of Legacy Wealth Management LLC MS’s holdings, making the stock its 27th largest position. Legacy Wealth Management LLC MS’s holdings in UnitedHealth Group were worth $2,941,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of UNH. Grant Private Wealth Management Inc lifted its stake in UnitedHealth Group by 6.8% in the 4th quarter. Grant Private Wealth Management Inc now owns 2,104 shares of the healthcare conglomerate’s stock valued at $695,000 after acquiring an additional 134 shares in the last quarter. Foguth Wealth Management LLC. bought a new position in UnitedHealth Group in the fourth quarter valued at $252,000. GAMMA Investing LLC lifted its position in UnitedHealth Group by 20.9% during the 4th quarter. GAMMA Investing LLC now owns 18,636 shares of the healthcare conglomerate’s stock worth $6,152,000 after buying an additional 3,216 shares in the last quarter. RIA Advisory Group LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $271,000. Finally, Davis Selected Advisers raised its holdings in UnitedHealth Group by 0.6% during the third quarter. Davis Selected Advisers now owns 1,139,303 shares of the healthcare conglomerate’s stock worth $393,401,000 after acquiring an additional 6,418 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 1.4%

UNH stock opened at $280.35 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.79 and a current ratio of 0.79. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $606.36. The company has a market capitalization of $254.47 billion, a PE ratio of 21.25, a price-to-earnings-growth ratio of 1.31 and a beta of 0.41. The company’s 50-day simple moving average is $298.52 and its 200 day simple moving average is $324.39.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, beating the consensus estimate of $2.09 by $0.02. The business had revenue of $113.73 billion for the quarter, compared to analyst estimates of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.UnitedHealth Group’s revenue was up 12.3% compared to the same quarter last year. During the same period last year, the firm posted $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were given a $2.21 dividend. The ex-dividend date was Monday, March 9th. This represents a $8.84 annualized dividend and a yield of 3.2%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 67.02%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on UNH shares. Royal Bank Of Canada lowered their price target on UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating on the stock in a research report on Wednesday, January 28th. Piper Sandler reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Tuesday, January 27th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Leerink Partners reduced their price target on UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. Finally, Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating on the stock in a research note on Friday, January 30th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $372.13.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.